V Brower. Show Affiliations »
Abstract
Mesh: See more » Biotechnology/economicsClinical Trials, Phase II as TopicCommerce/economicsComplementary TherapiesCost SavingsDietary Supplements/economicsDietary Supplements/standardsDrug ApprovalDrug Industry/economicsFood Labeling/legislation & jurisprudenceFood, Organic/economicsHealth Care SectorHumansJapanManaged Care ProgramsNutritional Physiological PhenomenaRecombinant Proteins/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Recombinant Proteins
Year: 1998 PMID: 9702769 DOI: 10.1038/nbt0898-728
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908